Remember Your Cleanroom Ps
February 12, 2019
When it comes to the crunch – the swab test – planning and preparation are the key to the best performance.
0 min read
January 2019
Welcome to the January issue. Upfront explores a collaborative project that aims to cut the cost of gene therapy and the EMA’s revised guidelines to better protect the environment. Minzhang Chen explains why the Chinese pharmaceutical market is already more advanced than many in the West imagine in “In My View,” while our cover feature explores the highs and lows for pharma in 2018. Ioannis Manolopoulos argues that serialization will certainly help in the battle against counterfeiters, but there are other steps that manufacturers can take, in NextGen; while George Chressanthis and Charlie Thompson explain why pharma could be the number one target for politicians in the US. In our latest Sitting Down With… Sir Alasdair Breckenridge considers how Brexit will impact pharma.
China’s Changing Future
February 11, 2019
The Chinese pharmaceutical market is already more advanced than many in the West imagine – and it only looks set to go in one direction.
0 min read
The Pharma Playground
January 31, 2019
Ups and downs, swings, merry-go-rounds… As ever, our industry will have to deal with its fair share of sociopolitical “fun” in 2019. What can we do? Address the challenges head on and celebrate the successes with verve.
0 min read
Business & Regulation
Drug Discovery
Research News
Cell & Gene
Facilities & Equipment
Technology & Manufacturing
Business & Trends
Here's to New Beginnings
January 31, 2019
Conversations around drug pricing look set to continue for years – and the resulting pressure will undoubtedly necessitate change. And yet, despite controversies surrounding this thorny issue, we should not forget to celebrate the positive side of pharma: fantastic progress in science and engineering is driving advances in discovery, development and manufacturing, with life-saving – and perhaps industry-changing – results.
0 min read
Pharma in the Firing Line
January 31, 2019
The 2018 Congressional midterm elections are over: the US is back to divided government. And with Democrats controlling the House, and Republicans expanding their majority in the Senate, the US pharma industry could be the number one target for politicians.
0 min read
Trials of a Medicine Maker
January 23, 2019
What lies ahead for Gene and Eva in 2019? Cell and gene therapies...
0 min read
Continuous Investment
January 22, 2019
How a collaborative project aims to cut the cost of gene therapy
0 min read
Proactive Policies
January 22, 2019
Gearing up for 2019, the EMA shares revised guidelines to better protect the environment, and unveils plans to protect us all in a health emergency
0 min read
Search and Destroy
January 22, 2019
Serialization will certainly help in the battle against counterfeiters, but there are other steps that manufacturers can take.
0 min read
Back to Nature
January 22, 2019
It’s time for pharma manufacturing to leave behind the highly energy-dependent and inflexible processes of the 20th century and embrace more sustainable and efficient biological approaches. Let’s “biologicalize” manufacturing.
0 min read
A Knight's Tale
January 22, 2019
Sitting Down With… Sir Alasdair Breckenridge; Chairman of the Advisory Board, the Centre of Regulatory Excellence of the Government of Singapore; Advisor, Sativa Investments; member of The Pistoia Alliance Advisory Board.
0 min read
Process Intensification: Getting More From Less
January 17, 2019
Intensifying or simplifying your bioprocess can mean more product, shorter manufacturing times, or lower costs –understanding what matters most is key to making the right decisions.
0 min read
Bon Appetit?
January 16, 2019
Scientists continue to unravel obesity – and seek new drugs to control weight gain
0 min read
Manufacture
Facilities & Equipment
Technology & Manufacturing
Small Molecules
Bioprocessing
Biopharma
Sponsored
Single-Use That’s Ready When You Are
November 22, 2017
Biopharma has embraced the benefits of single-use, but with a growing number of available components and highly customized assemblies, the supply chain becomes quite complex. Merck KGaA has designed a new program offering customized single-use assemblies.Biopharma has embraced the benefits of single-use, but the supply chain becomes quite complex. MilliporeSigmahas designed a new program offering customized single-use assemblies with reduced lead times, and an enhanced level of supply security.
1 min read
